Literature DB >> 16497292

Stretch-induced triphosphorylation of myosin light chain and myogenic tone in canine basilar artery.

Kazuo Obara1, Mayumi Uchino, Masayo Koide, Akihiro Yamanaka, Koichi Nakayama.   

Abstract

The relationship between phosphorylation of 20,000 Da myosin light chain (MLC20) and contraction in response to mechanical stretch was investigated in the canine basilar artery. A slow stretch (at a rate of 1 mm/s and a stimulus period for 15 min) increased triphosphorylated MLC20 despite lowered intracellular calcium concentration and mechanical activities, such as myogenic tone, shortening velocity and stiffness of the artery. Nicardipine, a Ca2+ channel blocker, and ML-9, a myosin light chain kinase (MLCK) inhibitor, partially inhibited the stretch-induced MLC20 phosphorylation. The remained phosphorylation was further reduced by calphostin C, a protein kinase C (PKC) inhibitor. Y-27632, a Rho-kinase inhibitor, inhibited phosphorylation of myosin light chain phosphatase and attenuated MLC20 phosphorylation. These results suggest that slow stretch induces triphosphorylation of MLC20, which is mediated by MLCK, PKC, and Rho-kinase, and that the triphosphorylation of MLC20 does not result in myogenic contraction, rather seems to counteract it.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497292     DOI: 10.1016/j.ejphar.2005.12.086

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Role of protein kinase Czeta and calcium entry in KCl-induced vascular smooth muscle calcium sensitization and feedback control of cellular calcium levels.

Authors:  Paul H Ratz; Amy S Miner
Journal:  J Pharmacol Exp Ther       Date:  2008-11-14       Impact factor: 4.030

2.  Ca2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response.

Authors:  Rosalyn P Johnson; Ahmed F El-Yazbi; Kosuke Takeya; Emma J Walsh; Michael P Walsh; William C Cole
Journal:  J Physiol       Date:  2009-04-09       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.